IN156319B - - Google Patents

Info

Publication number
IN156319B
IN156319B IN1081/CAL/82A IN1081CA1982A IN156319B IN 156319 B IN156319 B IN 156319B IN 1081CA1982 A IN1081CA1982 A IN 1081CA1982A IN 156319 B IN156319 B IN 156319B
Authority
IN
India
Application number
IN1081/CAL/82A
Other languages
English (en)
Inventor
Paolo Cornaglia Ferraris
Original Assignee
Co Pharma Corp Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT24120/81A external-priority patent/IT1140205B/it
Priority claimed from IT22848/82A external-priority patent/IT1152372B/it
Application filed by Co Pharma Corp Srl filed Critical Co Pharma Corp Srl
Publication of IN156319B publication Critical patent/IN156319B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN1081/CAL/82A 1981-09-24 1982-09-17 IN156319B (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT24120/81A IT1140205B (it) 1981-09-24 1981-09-24 Composti immuno-modulatori specifici, procedimento per la loro preparazone e composizioni farmaceutiche che li contengono
IT22848/82A IT1152372B (it) 1982-08-13 1982-08-13 Composti immonu-modulatori specifici,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono

Publications (1)

Publication Number Publication Date
IN156319B true IN156319B (en:Method) 1985-06-22

Family

ID=26328276

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1081/CAL/82A IN156319B (en:Method) 1981-09-24 1982-09-17

Country Status (10)

Country Link
US (1) US4567182A (en:Method)
EP (1) EP0077460B1 (en:Method)
KR (1) KR870001029B1 (en:Method)
AU (1) AU564576B2 (en:Method)
CA (1) CA1258149A (en:Method)
DE (1) DE3273785D1 (en:Method)
IN (1) IN156319B (en:Method)
LU (1) LU88813I2 (en:Method)
NL (1) NL960015I2 (en:Method)
PH (1) PH19112A (en:Method)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL73682A (en) * 1983-12-20 1991-08-16 Medivir Ab Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation
IT1213495B (it) * 1986-09-17 1989-12-20 Sigma Tau Ind Farmaceuti Processo per la preparazione dell'alfa-n-[(ipoxatin-9-il)pentilossicarbonil-]arginina
GB8719367D0 (en) * 1987-08-15 1987-09-23 Wellcome Found Therapeutic compounds
GB8725939D0 (en) * 1987-11-05 1987-12-09 Wellcome Found Therapeutic compounds
IT1223604B (it) * 1987-12-24 1990-09-29 Co Pharma Corp Srl Derivati purinici ad azione farmacologica
CA2005815C (en) * 1988-12-19 1999-08-03 Wellcome Foundation Limited (The) Antiviral acyclic nucleoside derivatives
GB8829571D0 (en) * 1988-12-19 1989-02-08 Wellcome Found Antiviral compounds
IT1241452B (it) * 1990-06-28 1994-01-17 Sigma Tau Ind Farmaceuti Derivati oligopeptidici dell'ipoxantina dotati di attivita' immunomodulante e composizioni farmaceutiche che li contengono
IT1244501B (it) * 1991-03-22 1994-07-15 Sigma Tau Ind Farmaceuti Derivati amminoacilici e oligopeptidici dell'allopurinolo dotati di attivita' immunostimolante e composizioni farmaceutiche che li contengono
US5994361A (en) * 1994-06-22 1999-11-30 Biochem Pharma Substituted purinyl derivatives with immunomodulating activity
US5559114A (en) * 1994-12-16 1996-09-24 Exley; Ray W. Treatment of autoimmune disease using 2-amino purine derivatives
US6455734B1 (en) 2000-08-09 2002-09-24 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
CN100345545C (zh) * 2003-06-18 2007-10-31 中国科学院上海药物研究所 6-氨基-α(R)-羟基-9H-嘌呤-9-丁酸乙酯的免疫抑制作用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
US4340726A (en) * 1980-03-14 1982-07-20 Newport Pharmaceuticals International, Inc. Esters

Also Published As

Publication number Publication date
EP0077460A2 (en) 1983-04-27
KR840001575A (ko) 1984-05-07
AU8808082A (en) 1983-03-31
LU88813I2 (fr) 1998-03-20
PH19112A (en) 1986-01-06
DE3273785D1 (en) 1986-11-20
EP0077460B1 (en) 1986-10-15
CA1258149A (en) 1989-08-01
AU564576B2 (en) 1987-08-20
KR870001029B1 (ko) 1987-05-25
EP0077460A3 (en) 1984-03-21
US4567182A (en) 1986-01-28
NL960015I2 (nl) 1998-03-02
NL960015I1 (nl) 1996-10-01

Similar Documents

Publication Publication Date Title
FR2497807B1 (en:Method)
CH655549B (en:Method)
FR2489954B1 (en:Method)
FR2500445B1 (en:Method)
FR2500943B3 (en:Method)
FR2499723B1 (en:Method)
FR2498802B1 (en:Method)
CH655399B (en:Method)
FR2502975B1 (en:Method)
FR2500143B1 (en:Method)
FR2502570B1 (en:Method)
FR2500803B3 (en:Method)
FR2498363B1 (en:Method)
GR77356B (en:Method)
FR2498266B3 (en:Method)
DE3231658A1 (en:Method)
FR2502118B3 (en:Method)
FR2499104B1 (en:Method)
CS8106049A (en:Method)
FR2501679B1 (en:Method)
FR2499292B3 (en:Method)
FR2498805B3 (en:Method)
FR2502589B3 (en:Method)
FR2499741B3 (en:Method)
FR2502282B3 (en:Method)